SelfWrap is currently in the research and development phase and is not available for sale in any country. Investigational Device. Limited by Federal Law to Investigational Use.

Contact Usinfo@venostent.com

2450 Holcombe Blvd, Suite J Houston, TX 77021

Follow Us

News & Press

VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial

VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial

VenoStent Technology Receives Breakthrough Device Designation by FDA

VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes

Kidney Disease: A Silent (and Costly) Killer

VenoStent Inks $2.3M

VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients

VenoStent Raises $2.3 Million in Seed Funding

VenoStent Raises $2.2 Million to Begin Clinical Trials

VenoStent wins Prestigious $500,000 KidneyX, Redefining Dialysis Prize

VenoStent Accepted into Y Combinator and Closes Oversubscribed SAFE Round

VenoStent Awarded Competitive Grant from National Institutes of Health

VenoStent Selected as Top 20 MassChallenge Company

VenoStent Closes Seed Round; Awarded NSF Phase II Grant

VenoStent Awarded LaunchTN Funds

Venostent Awarded $224,000 NSF STTR Phase I Grant

VenoStent @ Texas New Ventures Competition

Check Our Health Wildcatters 2017 Pitch Day!

VenoStent Accepted Into J&J JLabs @ TMC

VenoStent Enters Health Wildcatters Accelerator